Noha Shendy

[Front Line Genomics @FLGenomics]

Come along to The Festival of Genomics & Biodata, Boston to hear from @ShendyNoha (Postdoctoral Research Fellow, @jude_children) who will share insights on using #epigenetics to combat chemotherapy resistant cancer cells. Register now: https://t.co/6FAkTR4yGD #FOGBoston

[St. Jude Research @StJudeResearch]

Cuts in NIH research grants will have a lasting negative impact on science and medicine in the U.S. Grants will continue to fund specific research costs, but essential infrastructure like labs, advanced equipment and support staff are crucial for groundbreaking work.

[Noha Shendy @ShendyNoha]

@JunQiLab @StBaldricks @FilbinMariella @ADurbinLab @RousselMartine Congratulations 🎉🎊

[Noha Shendy @ShendyNoha]

@ADurbinLab @ElaineRitterPhD Congratulations!!!!!!🎉🎉🎉🎉

[Noha Shendy @ShendyNoha]

@bsteve00 @hatleylab Congratulations!!!!

[Noha Shendy @ShendyNoha]

@bsteve00 @ADurbinLab @NatureComms @TheAbraLab @StJude @JunQiLab @DanaFarber Thank you Bradley!

[Noha Shendy @ShendyNoha]

I am very excited to share that my recent work @ADurbinLab is published now in @NatureComms. Thank you for our collaborators (Martine Roussel’s lab and @TheAbraLab ) @StJude, @JunQiLab @DanaFarber and Ernst Schonbrunn’s lab @MoffittCancerCenter.

https://t.co/7J84yWR45O

[St. Jude Research @StJudeResearch]

��We found a new target that is druggable in this aggressive pediatric brain tumor that we’re continuing to study to try to help patients,” said @ADurbinLab.

[Noha Shendy @ShendyNoha]

@M_A_Ghonim @ADurbinLab @NatureComms @TheAbraLab @StJude @JunQiLab @DanaFarber Thank you, Dr. Mohammed!

[Noha Shendy @ShendyNoha]

@inobrodib We used this information to develop second generation molecules of CSS1477 with enhanced selectivity. Our study provides a new foundation for designing domain specific inhibitory small molecules to maximize the sensitivity of cancer cells to therapy.

[Noha Shendy @ShendyNoha]

We describe how Group 3 medulloblastoma cells were especially sensitive to EP300/CBP BRD inhibition by @inobrodib (CCS1477), as compared with HAT inhibition. Using structural biology, we determined the mechanism by which CCS1477 binds selectively to the BRD of EP300 and CBP.

[Noha Shendy @ShendyNoha]

@ADurbinLab @JunQiLab Yes! we did and getting her back. She is amazing.

[Noha Shendy @ShendyNoha]

@JunQiLab Happy birthday for her!

[Noha Shendy @ShendyNoha]

@hatleylab Congratulations!

[Noha Shendy @ShendyNoha]

@JunQiLab Congratulations!

[Noha Shendy @ShendyNoha]

@JunQiLab @ADurbinLab @StJudeResearch @RallyFoundation Thanks, Jun! Our work would not be accomplished without amazing collaborators like you @JunQiLab.

[Noha Shendy @ShendyNoha]

@ADurbinLab @StJudeResearch @RallyFoundation Thank you so much, Adam! It is an honor to be recognized for my work in pediatric cancer research. Grateful to be part of @ADurbinLab team and the impactful research community @StJudeResearch. Huge thanks for @RallyFoundation support.

[Noha Shendy @ShendyNoha]

@TheRobertsLab1 Congratulations, Sandi! You are an amazing scientist!

[The Roberts Lab @TheRobertsLab1]

Congratulations to Dr. Sandi Radko-Juettner on a beautiful talk and successful PhD defense this morning! 🥂🥳

[St. Jude Research @StJudeResearch]

Join us for the 4th Annual Bringing Chemistry to Medicine Symposium on Oct. 5-6. The event will feature leading experts in therapeutics, computational biology, and chemical biology. Register today. https://t.co/GeQcIqscAF